Research and Markets (http://www.researchandmarkets.com/research/0056a0/competitor_analysi) has announced the addition of the "Competitor Analysis: Alzheimer’s Disease Antibodies" report to their offering.
This report as of July 2008 provides a competitor analysis in the development pipeline of novel antibodies for passive immunotherapy of Alzheimer’s disease including those targeting amyloid-beta (beta-amyloid). Among the companies active in the field of new antibodies for passive immunotherapy of Alzheimer’s disease Wyeth, Elan, Pfizer, Roche and many others.
The report includes a compilation of current active projects in research and development of novel antibodies for passive immunotherapy of Alzheimer’s disease.
| Key Topics Covered: |
| - Pipeline of Alzheimer's Disease Antibodies |
| - Drug Codes, |
| - Target / Mechanism of Action, |
| - Class of Compound, |
| - Company, |
| - Product category, |
| - Indication, |
| - R&D Stage |
| Companies Mentioned: |
| - Wyeth |
| - Elan |
| - Pfizer |
| - Roche |
For more information visit http://www.researchandmarkets.com/research/0056a0/competitor_analysi.
Contacts:
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax
from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
